Phibro Animal Health Corporation
PAHC
$43.37
$1.313.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.88% | 12.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.88% | 12.47% | |||
| Cost of Revenue | 13.63% | 15.55% | |||
| Gross Profit | -1.39% | 6.35% | |||
| SG&A Expenses | -3.40% | 2.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.51% | 12.27% | |||
| Operating Income | -3.81% | 14.08% | |||
| Income Before Tax | -19.67% | 513.64% | |||
| Income Tax Expenses | -24.81% | 432.85% | |||
| Earnings from Continuing Operations | -17.51% | 555.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.51% | 555.57% | |||
| EBIT | -3.81% | 14.08% | |||
| EBITDA | -6.00% | 12.81% | |||
| EPS Basic | -17.47% | 555.60% | |||
| Normalized Basic EPS | -21.07% | 154.97% | |||
| EPS Diluted | -16.61% | 548.85% | |||
| Normalized Diluted EPS | -21.10% | 155.06% | |||
| Average Basic Shares Outstanding | -0.05% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.02% | -0.01% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.21% | -0.85% | |||